122 related articles for article (PubMed ID: 7009359)
1. Lactulose--a drug with antiendotoxin effect.
Liehr H; Englisch G; Rasenack U
Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of gut-derived endotoxemia with lactulose. An experimental study].
Hou RX
Zhonghua Wai Ke Za Zhi; 1991 Apr; 29(4):248-50, 272. PubMed ID: 1874117
[TBL] [Abstract][Full Text] [Related]
3. Control of endotoxinemia in liver disease by lactulose and paromomycin.
Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R
Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757
[TBL] [Abstract][Full Text] [Related]
4. Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice.
Ditter B; Urbaschek R; Urbaschek B
Gastroenterology; 1983 Jun; 84(6):1547-52. PubMed ID: 6341160
[TBL] [Abstract][Full Text] [Related]
5. Galactosamine hepatitis, endotoxemia, and lactulose.
van Vugt H; van Gool J; Thomas LL
Hepatology; 1983; 3(2):236-40. PubMed ID: 6832715
[TBL] [Abstract][Full Text] [Related]
6. Lactulose as an anti-endotoxin in liver transplantation.
Lancet; 1989 Oct; 2(8668):927-8. PubMed ID: 2571854
[No Abstract] [Full Text] [Related]
7. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
Liehr H; Heine WD
Hepatogastroenterology; 1981 Dec; 28(6):296-8. PubMed ID: 7345010
[No Abstract] [Full Text] [Related]
8. [Endotoxins of Gram-negative bacteria in liver diseases].
Bréchot C; Hecht Y; Ferrier JP
Gastroenterol Clin Biol; 1980 Apr; 4(4):289-305. PubMed ID: 6765202
[No Abstract] [Full Text] [Related]
9. [Anti-endotoxin therapy in liver diseases].
Scevola D; Barbarini G; Marone P; Azzini M; Filice C; Bernardi R
G Ital Chemioter; 1979; 26(1-2):241-56. PubMed ID: 400139
[No Abstract] [Full Text] [Related]
10. Lactulose as an antiendotoxin in experimental colitis.
Gardiner KR; Erwin PJ; Anderson NH; McCaigue MD; Halliday MI; Rowlands BJ
Br J Surg; 1995 Apr; 82(4):469-72. PubMed ID: 7613887
[TBL] [Abstract][Full Text] [Related]
11. Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.
Greve JW; Gouma DJ; von Leeuwen PA; Buurman WA
Gut; 1990 Feb; 31(2):198-203. PubMed ID: 2311978
[TBL] [Abstract][Full Text] [Related]
12. Incidence of endotoxemia in pigs with ischemic hepatic necrosis treated by hemodialysis. Prevention of endotoxemia with lactulose.
de Groot GH; Schalm SW; Batavier P; Maas HC; Schicht I
Hepatogastroenterology; 1983 Dec; 30(6):240-2. PubMed ID: 6676144
[TBL] [Abstract][Full Text] [Related]
13. Experimental and clinical study of lactulose in obstructive jaundice.
Pain JA; Bailey ME
Br J Surg; 1986 Oct; 73(10):775-8. PubMed ID: 3768644
[TBL] [Abstract][Full Text] [Related]
14. Cytoprotective effect of 16, 16' dimethyl prostaglandin E2 and some drugs on an acute galactosamine induced liver damage in rat.
Stachura J; Tarnawski A; Szczudrawa J; Bogdał J; Mach T; Klimczyk B; Kirchmayer S
Folia Histochem Cytochem (Krakow); 1980; 18(4):311-7. PubMed ID: 7203270
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
Nagakawa J; Hirota K; Hishinuma I; Miyamoto K; Sonoda J; Yamanaka T; Katayama K; Yamatsu I
J Pharmacol Exp Ther; 1993 Jan; 264(1):496-500. PubMed ID: 8423547
[TBL] [Abstract][Full Text] [Related]
16. [Possible therapeutic uses of lactulose other than in porto-systemic encephalopathy].
Alvaro D; Angelico M; Attili AF
Minerva Dietol Gastroenterol; 1986; 32(1):67-72. PubMed ID: 3703321
[No Abstract] [Full Text] [Related]
17. [Treatment of healthy salmonella carriers with lactulose beta-galactosido-fructose (author's transl)].
Hoffmann K
Dtsch Med Wochenschr; 1975 Jun; 100(26):1429-31. PubMed ID: 238823
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral supplementation of lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine.
Kasravi FB; Adawi D; Molin G; Bengmark S; Jeppsson B
J Hepatol; 1997 Feb; 26(2):417-24. PubMed ID: 9059965
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.
Lam C; Hildebrandt J; Schütze E; Rosenwirth B; Proctor RA; Liehl E; Stütz P
Infect Immun; 1991 Jul; 59(7):2351-8. PubMed ID: 1646770
[TBL] [Abstract][Full Text] [Related]
20. [Bifidum-milk and lactulose in the therapy of chronic liver diseases].
Müting D; Reikowski J; Rosskopf U
Med Welt; 1980 May; 31(22):857-60. PubMed ID: 7392944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
